Condition
Attention Deficits
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06791785Not ApplicableNot Yet Recruiting
The Effect Of Aromatherapy Applied To Children Aged 9-12 On Exam Anxiety, Attention Deficit and Academic Success
NCT01749800Not ApplicableTerminated
Galvanic Vestibular Stimulation and Motor Training in Traumatic Brain Injury Survivors
NCT02178995Phase 4Completed
Methylphenidate Treatment of Attention Deficits in Epilepsy
NCT01883830Not ApplicableCompleted
Xbox in the Rehabilitation of Chronic Traumatic Brain Injury
Showing all 4 trials